Bafilomycin application has been shown to reduce cell growth in various cancer cell lines across multiple cancer types by induction of apoptosis. Additionally, in vitro bafilomycin's anti-proliferative effect appears to be specific to cancer cells over normal cells, which is seen with selective inhibition of hepatoblastoma cell growth compared to healthy hepatocytes.
Bafilomycin application has been shown to reduce cell growth in various cancer cell lines across different types of cancers by triggering apoptosis.  In vitro studies show that bafilomycin specifically inhibits the growth of cancer cells, while sparing normal cells like those found in healthy liver tissue. This effect is particularly evident when comparing the growth of hepatoblastoma cells with healthy hepatocytes.